Your search for "Classical Swine Fever" return 11 results.
Ceva Animal Health strengthens its presence in Vietnam by signing several development projects for the livestock sector >
Signing ceremony for the agreement of research and development
Compatibility of Coglapest® and Coglapix® vaccines in pigs >
This study was conducted in order to test the compatibility of Coglapix® and Coglapest® vaccines, when the latter was reconstituted in Coglapix®.
Coglapest® >
Frequently Asked Questions
VETRIMOXIN® LA - Technical profile >
Vetrimoxin® LA is the leading product in the Ceva anti-infective range. Within the group of historical antibiotics, the product has an extensive experience in the market as leader in its segment being...
COGLAPEST®: Comparison With Two Modified Live Vaccines Containing A Chinese Strain >
Two field trials, conducted one in Thailand and one in the Philippines, compare the immunogenicity of COGLAPEST® from Ceva Animal Health versus two different commercial modified live vaccines containi...
Coglapix® and the procedure to control pleuro-pneumonia caused by Actinobacillus pleuropneumoniae (APP) >
In the recent years, the pig farms in the whole world always control APP following a strict process including diagnosis, prevention, treatment and regular monitoring together with good farm practices...
Porcine Pleuropneumonia: From A Good Detection To A Good Protection >
In this new issue of Axis, we would like to have anupdate on the swine pleuro-pneumonia, the management of the disease and the prevention possibilities. Ceva Santé Animale has developed a new vaccine,...
What is the best vaccination program with Coglapest® for sows? A new study that changes the usual concepts >
A trial in a big farm in the south of Thailand has confirmed it is better to vaccinate all the sow at the same date before farrowing.
Disease Informations >
Informations about the common diseases in pig
Vaccines >
Ceva is committed to swine vaccines with its Research and Development sites located in different continents worldwide investing substantial resources in innovation and production.